Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
The use of SGLT-2i is associated with a decreased risk of dementia incidence in the study population in mainland China.
Authors
- Hou-Yu Zhao (ORCID: https://orcid.org/0000-0002-4546-9342)
- Lin Zhuo (ORCID: https://orcid.org/0000-0001-9188-702X)
- Siyan Zhan (ORCID: https://orcid.org/0000-0001-7252-5349)
- Baixue Zhang
- Yueqi Yin (ORCID: https://orcid.org/0000-0003-1164-4074)
- Peng Shen (ORCID: https://orcid.org/0000-0002-0176-127X)
- Yexiang Sun (ORCID: https://orcid.org/0009-0006-2915-7521)
- Zhi-Qin Jiang
Institutions
- Chongqing University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Beijing Academy of Artificial Intelligence (CN)
- Peking University Third Hospital (CN)
- Guang’anmen Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1111/dom.16239
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation